Sanofi partners with HHS to work on COVID-19 vaccine

Sanofi’s vaccine unit has united with the US Department of Health and Human Services (HHS) to develop a vaccine for the COVID-19 virus, which has so far killed more than 2,000 people worldwide.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

HHS commits to IP transparency following watchdog’s criticism

26 November 2020 The US Department of Health and Human Services will reveal more information regarding its licensing of IP to private companies for drug development, it has confirmed in a letter to a congressional watchdog.

Big Pharma

Sanofi under fire over priority US access to COVID-19 vaccine

15 May 2020 Sanofi is facing criticism after CEO Paul Hudson said the US was likely to have priority access on any COVID-19 vaccine produced by the French pharmaceutical company.

Big Pharma

Sanofi announces new vaccine project as Australia begins animal tests

2 April 2020 France’s Sanofi Pasteur and US biotechnology company Translate Bio have joined the race to develop a vaccine for SARS-CoV-2, the coronavirus behind COVID-19.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Sanofi partners with HHS to work on COVID-19 vaccine

More on this story

Editor's picks

Editor's picks

More features